BDBM479461 US10894807, ID P281
SMILES: OC(=O)CCC(NC(=O)N[C@@H](CCCCNC(=O)N1CCN(CC1)C(=O)CCC(CCC(=O)N1CCN(CC1)C(=O)NCCCC[C@H](NC(=O)NC(CCC(O)=O)C(O)=O)C(O)=O)NC(=O)c1ccc(cc1)-n1cc(CCCF)nn1)C(O)=O)C(O)=O
InChI Key: InChIKey=YAZAAWJNMQEXPH-LBTFUVSJSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glutamate carboxypeptidase 2 (Homo sapiens (Human)) | BDBM479461 (US10894807, ID P281) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Siemens Medical Solutions USA, Inc. US Patent | Assay Description The inhibitory activity of all compounds was determined using a fluorescent assay of human PSMA activity. The enzyme used in the assay was purchased ... | US Patent US10894807 (2021) | |||||||||||
More data for this Ligand-Target Pair |